About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

CCHR Issues Alert on Mortality Risk of Psychiatric Drugs After Researcher Estimates They Are Third Leading Cause of Death in U.S.

Hospital records and coroners’ reports often record deaths linked to prescription drugs as due to natural or unknown causes, rather than from the adverse effects of the drugs – especially psychiatric drug-related deaths, a leading researcher says.

Citizens Commission on Human Rights (CCHR) is alerting the public to the risks of adverse effects from psychiatric drugs that may result in death, after a leading medical researcher estimated that psychiatric drugs are the third most common cause of death in the U.S., after heart disease and cancer.

In an article published by the Brownstone Institute, Peter Gøtzsche, MD, director of the Institute for Scientific Freedom and a former professor of clinical research design and analysis at the University of Copenhagen, writes that “in hospital records and coroners’ reports, deaths linked to prescription drugs are often considered to be from natural or unknown causes,” rather than from the adverse effects of the drugs. He adds that “this misconception is particularly common for deaths caused by psychiatric drugs.”

By way of example, he says that when young patients taking antipsychotic drugs die suddenly, it is typically considered a natural death. However, he counters that it is not natural for young people to die and that antipsychotics are known to carry the risk of fatal heart arrhythmias.

Gotzsche says his analysis corrects for the limitations, biases, missing data, and lack of sufficient patient follow-up in published placebo-controlled, randomized studies that report deaths from psychiatric drug use. Because young people have a much lower risk of death than the elderly, the analysis focuses on estimating a death rate in people aged 65 and older. He says his approach was conservative, as his estimates do not include psychiatric drug-related deaths occurring in hospitals or in those under the age of 65. 

Gotzsche used data from the U.S. Food and Drug Administration (FDA) and from published research studies for three classes of psychiatric drugs: selective serotonin reuptake inhibitor (SSRI) antidepressants, antipsychotic drugs, and antianxiety/hypnotic drugs. He estimates that for each of these drug classes, the drugs cause the death of two in every 100 older patients each year in the U.S., for an annual mortality rate of 2%.  He notes that patients taking several psychiatric drugs are at an even greater risk of death.

“I therefore do not doubt that psychiatric drugs are the third leading cause of death after heart disease and cancer,” he wrote.

Currently, nearly 11 million Americans aged 65 and older are on antidepressants, over 2 million are on antipsychotics, and 8.5 million are on antianxiety drugs. Many are taking more than one psychiatric drug or drugs in more than one psychiatric drug class.  Gotzsche’s estimates suggest several hundred thousand deaths annually among older Americans could rightly be attributed to psychiatric drugs.

In criticizing the inaction of lawmakers on what he says are preventable deaths, Gotzsche writes, “If such a hugely lethal pandemic had been caused by a microorganism, we would have done everything we could to get it under control.”

Citizens Commission on Human Rights continues to advocate for a government investigation on the dangers of psychiatric drugs and to raise public awareness of the risks of the drugs.

Because consumers can only make fully informed decisions about taking or discontinuing psychiatric drugs when they are given accurate information about the known risks of the drugs, CCHR encourages patients to insist on getting full disclosure of those risks and to discuss those risks with their prescribers.

WARNING: Anyone wishing to discontinue or change the dose of a psychiatric drug is cautioned to do so only under the supervision of a physician because of potentially dangerous withdrawal symptoms.

About the company: The Citizens Commission on Human Rights was co-founded in 1969 by members of the Church of Scientology and the late psychiatrist and humanitarian Thomas Szasz, M.D., recognized by many academics as modern psychiatry’s most authoritative critic, to eradicate abuses and restore human rights and dignity to the field of mental health.

Contact Info:
Name: Anne Goedeke
Email: Send Email
Organization: Citizens Commission on Human Rights, National Affairs Office
Address: Washington, DC
Phone: 202-349-9267
Website: http://www.cchrnational.org

Video URL: https://www.youtube.com/watch?v=tlR4pntJboI

Release ID: 89127988

If there are any deficiencies, discrepancies, or concerns regarding the information presented in this press release, we kindly request that you promptly inform us by contacting error@releasecontact.com. Our dedicated team is committed to addressing any identified issues within 8 hours to guarantee the delivery of accurate and reliable content to our esteemed readers.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.